Tender Title: Diclofenac + Linseed Oil + Menthol + Methyl Salicylate Topical Forms (V2)
Tender Reference Number: 196fd260a
Issuing Authority/Department: Department of Atomic Energy
Scope of Work and Objectives
The primary objective of this tender is to acquire diclofenac, linseed oil, menthol, and methyl salicylate topical forms in sufficient quantities to meet the operational needs of the Department of Atomic Energy. The successful bidder will be responsible for supplying a total of 1500 units of the specified topical formulations. The scope encompasses manufacturing, quality control, and adherence to safety regulations to ensure that all products meet the required efficacy and safety standards.
Eligibility Criteria
Tender participants must fulfill specific eligibility criteria to qualify for bid submission. Prospective bidders should:
- Be a registered organization with relevant manufacturing capabilities.
- Provide proof of past performance in delivering similar products.
- Hold all necessary licenses and certifications required to manufacture and distribute pharmaceutical products.
Technical Requirements
Vendors must adhere to the following technical requirements:
- All products must meet specified quality standards valid for pharmaceutical preparations.
- Submissions must include detailed formulations and methods of manufacturing.
- Applicants will need to provide quality assurance documentation that complies with industry standards.
Financial Requirements
Bidders should be prepared to demonstrate their financial stability by providing:
- Audited financial statements for the past three years.
- A bank guarantee or other forms of financial security as stipulated in the bid requirements.
Document Submission Details
Interested parties should ensure that all necessary documents are submitted electronically through the designated procurement platform or via a secure method as specified in further instructions. Required documents include:
- Completed bid form.
- Technical proposal.
- Financial proposal.
- Compliance certificates.
Special Provisions
This tender encourages participation from Micro, Small, and Medium Enterprises (MSEs) and startups by offering financial incentives and support. Furthermore, preference will be given to bids that comply with 'Make in India' policies, promoting local manufacturing.
Evaluation Process
The evaluation of bids will follow a structured process:
- Compliance with technical specifications will be assessed first.
- Financial evaluations will follow, considering the overall deliverability and cost-effectiveness.
- Final evaluations will take into account the bidder’s capability, past experience, and quality assurance mechanisms.
Delivery Locations
Successful bidders will be required to deliver the products to specified locations as designated by the Department of Atomic Energy. Inclusions of delivery schedules and logistic arrangements will be discussed post-bid selection.
Contact Information
For any inquiries related to this tender, bidders are advised to refer to the website or procurement platform from which the tender is published to find contact details for relevant personnel.
General Information
Evaluation and Technical Information
Tender Documents
4 DocumentsSimilar Tenders
Frequently Asked Questions
The eligibility requirements include being a registered entity, fulfilling all licensing and manufacturing prerequisites, and demonstrating prior experience in supplying pharmaceutical products. Bidders are encouraged to provide documentation supporting their qualifications, including references and evidence of past deliveries.
Participants must include a comprehensive set of documents such as the completed bid form, technical and financial proposals, as well as compliance certificates. It is crucial that all documents conform to the specified submission formats and requirements outlined in the tender documentation to ensure acceptance.
The technical specifications entail the formulations of diclofenac, linseed oil, menthol, and methyl salicylate. All products must adhere to stringent quality and manufacturing standards, ensuring their safety and efficacy for medicinal use. Bidders must provide detailed manufacturing processes and quality assurance credentials.
Bidders are required to present an Earnest Money Deposit (EMD) as per the guidelines. Post-award, performance security will also be mandated. Payment terms will be negotiated following successful delivery and compliance checking of the products in accordance with the contractual stipulations.
The evaluation process comprises an initial review of document compliance, followed by technical assessments, and financial evaluations. The final selection will be determined based on the overall suitability, past performance history, and adherence to quality standards as stipulated in the tender notice. Bidders will be informed of the results via formal communication through the procurement platform.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders